Joseph T. Kennedy, VP and General Counsel at Transcept Pharmaceuticals Inc (TSPT), sold 34,600 shares at $7.87 ($272K) on 2011-11-23, disclosed to the SEC on 2011-11-28.
Scheduled sale ($272k) by VP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AMRN | SELL | 2019-05-02 | $509K | — | Filing → |
| AMRN | SELL | 2019-04-01 | $1.1M | — | Filing → |
| AMRN | SELL | 2019-03-01 | $1.1M | — | Filing → |